JRCT ID: jRCT1052200041
Registered date:31/07/2020
Exploratory study of severity index for COVID-19 patients
Basic Information
| Recruitment status | Complete |
|---|---|
| Health condition(s) or Problem(s) studied | Novel Coronavirus Infectious Disease (COVID-19) |
| Date of first enrollment | 30/07/2020 |
| Target sample size | 40 |
| Countries of recruitment | |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Transition of Respiratory Stability Time |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | 1)20 years old or older at informed consent 2)SARS-CoV-2 positive or pneumonia 3)Patients who have given written consent to participate |
| Exclude criteria | 1)Patients who are considered inappropriate for inclusion in the study by the investigator |
Related Information
| Primary Sponsor | sawa Yoshiki |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Japan Agency for Medical Research and Development |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Shigeru Miyagawa |
| Address | 2-15 Yamadaoka, Suita, Osaka, Japan Osaka Japan 565-0871 |
| Telephone | +81-6-6879-3154 |
| saisentan@tissue.med.osaka-u.ac.jp | |
| Affiliation | Osaka University Hospital |
| Scientific contact | |
| Name | Yoshiki sawa |
| Address | 2-15 Yamadaoka, Suita, Osaka, Japan Osaka Japan 565-0871 |
| Telephone | +81-6-6879-3154 |
| sawasec@surg1.med.osaka-u.ac.jp | |
| Affiliation | Osaka University Hospital |